Getting semaglutide requires a prescription from a licensed healthcare provider, and the path you take depends on whether you need it for weight management or type 2 diabetes. The medication comes in three brand names, each with different approved uses, and your eligibility hinges on specific BMI thresholds, health conditions, and sometimes your insurance plan’s willingness to cover it. Here’s what the process actually looks like.
Which Version of Semaglutide You Need
Semaglutide is sold under three brand names, and they aren’t interchangeable. Ozempic is a once-weekly injection approved for type 2 diabetes. Rybelsus is a daily oral tablet, also for type 2 diabetes. Wegovy is approved specifically for weight management and comes as both a weekly injection and a daily oral tablet. All three contain semaglutide, but at different doses and for different purposes.
If your goal is weight loss, Wegovy is the version your provider will prescribe. Ozempic is sometimes prescribed off-label for weight management, but insurance is far less likely to cover it for that purpose since it isn’t FDA-approved for it. Knowing which version fits your situation matters because it shapes everything from eligibility to cost.
Who Qualifies for a Prescription
For Wegovy (the weight management version), you need to meet one of two criteria: a BMI of 30 or higher, which falls in the obesity range, or a BMI of 27 to 29.9 with at least one weight-related health condition such as high blood pressure, high cholesterol, or type 2 diabetes. These thresholds apply to adults and to adolescents aged 12 and older with obesity.
For Ozempic or Rybelsus, you need a diagnosis of type 2 diabetes. Your provider will also screen for conditions that rule out semaglutide entirely. The two absolute disqualifiers are a personal or family history of medullary thyroid cancer and a condition called Multiple Endocrine Neoplasia syndrome type 2. Beyond those hard stops, your provider will want to discuss risks carefully if you have a history of pancreatitis, severe digestive motility problems like gastroparesis, certain diabetic eye conditions, low body weight, or are pregnant.
What Happens at the Doctor’s Visit
Your provider will take a full health history, check your BMI, and ask about weight-related conditions. If you have type 2 diabetes, expect a diabetic eye exam (or recent results from one within the past 12 months) before starting treatment. Blood work to check kidney function, blood sugar levels, and thyroid markers is standard, though the exact tests vary by provider.
The visit doesn’t need to be complicated. Many people get a prescription from their primary care doctor. You don’t necessarily need to see an endocrinologist or obesity specialist, though either can prescribe it. Telehealth providers also prescribe semaglutide in many states, which can speed up the process if you’re comfortable with a virtual evaluation.
Dealing With Insurance and Prior Authorization
This is where many people hit a wall. Coverage for semaglutide varies wildly between insurance plans, and there’s no guarantee yours will cover it. Each insurer’s medical director decides whether weight loss medications are included in the plan’s formulary. Even if your plan does cover Wegovy, you’ll likely face prior authorization, meaning your doctor has to submit documentation proving you meet the criteria before the pharmacy can fill it.
Some insurers require more than just a qualifying BMI. Your plan may demand evidence that you’ve tried lifestyle changes first, or that you have a documented obesity-related condition like hypertension or sleep apnea. A high BMI alone may not be sufficient. If your initial request is denied, your doctor can file an appeal, and many denials are overturned with additional documentation.
For diabetes indications, Ozempic coverage tends to be more straightforward since insurers are generally more willing to cover medications for blood sugar management. But step therapy requirements are common, meaning your insurer may require you to try older, cheaper diabetes medications first before approving semaglutide.
What It Costs Out of Pocket
The list price for Wegovy is $1,349 per month. Ozempic lists at about $1,028 per fill. Those numbers rarely reflect what you’ll actually pay, but they’re worth knowing as a ceiling.
If you have commercial insurance and a manufacturer savings card, you can pay as little as $25 per fill for either Wegovy or Ozempic, with up to $100 per month in savings applied. The Ozempic savings card is valid for up to 48 months. These savings cards are not available if you’re on Medicare, Medicaid, TRICARE, or VA benefits.
For people paying entirely out of pocket, Novo Nordisk now offers direct pricing through its NovoCare Pharmacy. Wegovy starter doses (0.25 mg and 0.5 mg) are $199 per month through June 30, 2026. After that introductory period, or for higher maintenance doses, the price is $349 per month. The highest dose, Wegovy HD at 7.2 mg, runs $399 per month. The oral version of Rybelsus is available at $149 per month for starter doses through NovoCare. These cash-pay options don’t require insurance at all.
How Dosing Works Once You Start
Semaglutide isn’t prescribed at a full dose from day one. Every version uses a gradual dose escalation to reduce side effects, particularly nausea. For Wegovy injections, you start at 0.25 mg weekly and step up every four weeks through 0.5 mg, 1 mg, and 1.7 mg before reaching the standard maintenance dose of 2.4 mg weekly. That ramp-up takes about four months. Patients who tolerate 2.4 mg well can increase to a maximum of 7.2 mg weekly.
For the oral Wegovy tablet, you start at 1.5 mg daily and increase every 30 days through 4 mg and 9 mg before reaching a maintenance dose of 25 mg daily. The oral version has a specific routine: take it first thing in the morning on an empty stomach with a small amount of water (no more than 4 ounces), then wait at least 30 minutes before eating, drinking anything else, or taking other medications.
Injections are given once weekly on the same day each week, at any time of day, in the abdomen, thigh, or upper arm. The pens are pre-filled and use a small needle, similar to insulin pens.
Why Compounded Semaglutide Is Risky
During recent supply shortages, compounding pharmacies began making their own versions of semaglutide. As of early 2026, semaglutide is no longer on the FDA drug shortage list, which changes the legal landscape for compounding. But compounded versions are still circulating online and through some clinics.
The FDA has issued direct warnings about compounded semaglutide. These products don’t undergo any premarket review for safety, quality, or effectiveness. The agency has received reports of hospitalizations tied to dosing errors with compounded injectable products. The problems stem from several sources: compounders using salt forms of semaglutide (like semaglutide sodium or semaglutide acetate) that are chemically different from the base form used in approved drugs, products available in varying concentrations that lead to measurement errors, and the addition of unproven extra ingredients like vitamin B-12, L-carnitine, or NAD whose safety in combination with semaglutide has never been established.
Reported overdose events from compounded products include severe nausea, vomiting, abdominal pain, fainting, dehydration, acute pancreatitis, and gallstones. If you’re offered compounded semaglutide at a steep discount, particularly from an online source, the lower price reflects genuinely lower quality control.
The Fastest Path to a Prescription
If you meet the BMI criteria, the most efficient route is booking an appointment (in person or telehealth) with a provider who regularly prescribes weight management medications. Come prepared with your weight history, any documented weight-related conditions, and a list of medications you’ve tried. If your provider agrees you’re a candidate, they’ll write the prescription and, if needed, start the prior authorization process with your insurer.
While waiting for insurance approval, ask your provider about the NovoCare cash-pay option to start treatment sooner. The starter doses are the cheapest tier, and since everyone begins at a low dose regardless, the first two months of treatment overlap with the lowest price point. You can always switch to insurance-covered fills once authorization comes through.